Integrating Extended Reality Into Primary Care Chronic Pain Programs via the REDOCVR Intervention: Real-World Implementation Feasibility and Usability Study
JMIR XR and Spatial Computing · 2025-10-31 · 2 · e82858-e82858
DOI: 10.2196/82858 ↗Abstract
Abstract Background Chronic pain management in public health services often struggles with limited engagement, emotional burden, and medication use. Extended reality (XR) shows promise in specialized settings, but evidence for codesign and integration into primary care remains limited. Objective This study aimed to examine the feasibility, usability, and real-world implementation of REDOCVR [RE (Reeducació), DOC (Dolor Crònic), VR (Virtual Reality)], an XR-supported psychoeducational program, and to explore preliminary clinical outcomes during its integration into chronic pain groups in public primary care centers. Methods This was a nonrandomized, hybrid type 2 phased implementation study conducted in 3 primary care centers in Catalonia, Spain. The intervention built on existing multidisciplinary psychoeducational chronic pain groups led by psychologists and physiotherapists. In collaboration with patients, XR modules were codesigned and incorporated to enhance mindfulness, cognitive reframing, and motor activation activities already established in routine care. In total, 8 weekly sessions included 15‐20 minutes of this content, with a supervised medication tapering protocol included in later groups. Primary outcomes were implementation measures (adherence, tolerability, System Usability Scale, and satisfaction). Secondary outcomes included patient-reported clinical measures (Warwick-Edinburgh Mental Well-being Scale [WEMWBS], Hospital Anxiety and Depression Scale [HADS], Central Sensitization Inventory, and EuroQol – 5 Dimensions – 5 Levels) and medication changes, assessed at baseline, post-intervention, and 5-month follow-up. Results In total, 42 participants were enrolled, and 36 (85.7%) completed the intervention and all assessments. Adherence was high, and no serious adverse events occurred, with minimal cybersickness reported (5.6%). Patient usability was strong (mean 81.4, 95% CI 75.6‐87.1), and overall satisfaction was high (mean 82.4, 95% CI 78.5‐86.4). Professional usability was moderate (mean 59.1, 95% CI 51.6‐66.5). Statistically significant improvements were observed in emotional well-being (Warwick-Edinburgh Mental Well-being Scale mean change 4.8, 95% CI 2.9‐6.7; Cohen d =0.86), anxiety (HADS-A –2.5, 95% CI –3.8 to –1.2; Cohen d =0.66), and depression (HADS-D –1.6, 95% CI –2.5 to –0.7; Cohen d =0.62) (all P
EUVIMED